Home › Marginal Zone Lymphoma › Massachusetts › Boston
Marginal Zone Lymphoma clinical trials in Boston, MA
8 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
RecruitingPhase 2
- Dana Farber Cancer Institute (Data Collection and Specimen Analysis), Boston
- Beth Israel Deaconess Medical Center (Data Collection Only), Boston
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
RecruitingPhase 1
- Massachusetts General Hospital, Boston
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Dana Farber Cancer Institute, Boston
Epco, Zanu, Ritux for R/R FL or MZL
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
RecruitingPhase 2
- Beth Israel Deaconess Medical Center, Boston
Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
- Beth Israel Deaconess Medical Center, Boston
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
RecruitingPhase 2
- Dana Farber Cancer Institute, Boston
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY10 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Columbus, OH8 studies
- Seattle, WA8 studies
- Edison, NJ8 studies
- Houston, TX8 studies
- Miami, FL7 studies
- Rochester, MN7 studies
- Denver, CO7 studies
- Nashville, TN7 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.